# Cytek Biosciences

Cytek Biosciences is a Medical Devices / Biotechnology based in Fremont, United States.

## Overview

- **Organization type:** Medical Devices / Biotechnology
- **Headquarters:** Fremont, United States
- **Region:** North America
- **Address:** Fremont, CA, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** cytekbio.com
- **LinkedIn:** https://www.linkedin.com/company/cytek-biosciences

## Regulatory record

- **Reports private funds:** No

## About

Cytek Biosciences is a company specializing in cell analysis solutions for the biomedical research sector. It offers flow cytometry systems, reagents, and software for studying immune cells. Cytek's products are used in research areas such as immuno-oncology, infectious diseases, and drug discovery.

## Sectors

- Life Sciences Tools
- Diagnostics
- Flow Cytometry

## Offices

- Shanghai, China

## People

- Wenbin Jiang — CEO
- Ming Yan — CFO

## Questions

### Who runs investment decisions at Cytek Biosciences?

Wenbin Jiang is CEO and founder. The company is publicly traded, so investment decisions are governed by a board of directors, not a centralized family office. Jiang and the executive team drive strategic and capital-allocation decisions.

### How does Cytek Biosciences source proprietary deal flow?

Cytek is a technology company, not an investment firm. Its growth comes from internal R&D, licensing agreements, and targeted acquisitions—such as the 2023 purchase of Levitas Bio's flow cytometry assets. The firm does not operate a separate venture arm.

### What investment stages does Cytek Biosciences typically target?

Cytek does not make external investments. Its capital activities focus on internal product development and occasional bolt-on acquisitions of complementary technologies or IP.

### Which sectors does Cytek Biosciences explicitly avoid?

The company focuses exclusively on life science tools, specifically flow cytometry and cell analysis. It does not participate in any other investment sectors or asset classes.

### How is Cytek Biosciences related to its parent or related vehicles?

Cytek is an independent public company. Its largest institutional shareholders include Warburg Pincus and other venture investors. There is no family office or single controlling shareholder.

## Related profiles

- [Freedom Mortgage](https://altss.com/profile/freedom-mortgage)
- [A-Star](https://altss.com/profile/a-star)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/cytek-biosciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology